176 related articles for article (PubMed ID: 9651226)
1. Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine.
Banner LR; Patterson PH; Allchorne A; Poole S; Woolf CJ
J Neurosci; 1998 Jul; 18(14):5456-62. PubMed ID: 9651226
[TBL] [Abstract][Full Text] [Related]
2. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia.
Safieh-Garabedian B; Poole S; Allchorne A; Winter J; Woolf CJ
Br J Pharmacol; 1995 Aug; 115(7):1265-75. PubMed ID: 7582555
[TBL] [Abstract][Full Text] [Related]
3. Studies using leukemia inhibitory factor (LIF) knockout mice and a LIF adenoviral vector demonstrate a key anti-inflammatory role for this cytokine in cutaneous inflammation.
Zhu M; Oishi K; Lee SC; Patterson PH
J Immunol; 2001 Feb; 166(3):2049-54. PubMed ID: 11160255
[TBL] [Abstract][Full Text] [Related]
4. Regulation of signal transducer, GP13O and the LIF receptor in acute inflammation in vivo.
Geisterfer M; Gauldie J
Cytokine; 1996 Apr; 8(4):283-7. PubMed ID: 9162216
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
Chesnokova V; Melmed S
Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Chesnokova V; Melmed S
Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823
[TBL] [Abstract][Full Text] [Related]
7. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
Leánez S; Hervera A; Pol O
Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice.
Narita M; Shimamura M; Imai S; Kubota C; Yajima Y; Takagi T; Shiokawa M; Inoue T; Suzuki M; Suzuki T
Neuroscience; 2008 Mar; 152(2):477-86. PubMed ID: 18262365
[TBL] [Abstract][Full Text] [Related]
9. Probucol Ameliorates Complete Freund's Adjuvant-Induced Hyperalgesia by Targeting Peripheral and Spinal Cord Inflammation.
Zucoloto AZ; Manchope MF; Borghi SM; Dos Santos TS; Fattori V; Badaro-Garcia S; Camilios-Neto D; Casagrande R; Verri WA
Inflammation; 2019 Aug; 42(4):1474-1490. PubMed ID: 31011926
[TBL] [Abstract][Full Text] [Related]
10. Anti-nociceptive effects of Tanshinone IIA (TIIA) in a rat model of complete Freund's adjuvant (CFA)-induced inflammatory pain.
Sun S; Yin Y; Yin X; Cao F; Luo D; Zhang T; Li Y; Ni L
Brain Res Bull; 2012 Sep; 88(6):581-8. PubMed ID: 22705002
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor induces mechanical allodynia but not thermal hyperalgesia in the juvenile rat.
Thompson SW; Dray A; Urban L
Neuroscience; 1996 Apr; 71(4):1091-4. PubMed ID: 8684613
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 involvement in the induction of leukemia inhibitory factor mRNA expression following axotomy of sympathetic ganglia.
Carlson CD; Bai Y; Ding M; Jonakait GM; Hart RP
J Neuroimmunol; 1996 Nov; 70(2):181-90. PubMed ID: 8898726
[TBL] [Abstract][Full Text] [Related]
13. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha.
Woolf CJ; Allchorne A; Safieh-Garabedian B; Poole S
Br J Pharmacol; 1997 Jun; 121(3):417-24. PubMed ID: 9179382
[TBL] [Abstract][Full Text] [Related]
14. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor type 1 is overexpressed in neurons but not in glial cells within the rat superficial spinal dorsal horn in complete Freund adjuvant-induced inflammatory pain.
Holló K; Ducza L; Hegyi Z; Dócs K; Hegedűs K; Bakk E; Papp I; Kis G; Mészár Z; Bardóczi Z; Antal M
J Neuroinflammation; 2017 Jun; 14(1):125. PubMed ID: 28645297
[TBL] [Abstract][Full Text] [Related]
16. Gastrodin relieved complete Freund's adjuvant-induced spontaneous pain by inhibiting inflammatory response.
Sun T; Wang J; Li X; Li YJ; Feng D; Shi WL; Zhao MG; Wang JB; Wu YM
Int Immunopharmacol; 2016 Dec; 41():66-73. PubMed ID: 27816787
[TBL] [Abstract][Full Text] [Related]
17. Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.
Bianchi M; Franchi S; Ferrario P; Sotgiu ML; Sacerdote P
Eur J Pain; 2008 Apr; 12(3):284-92. PubMed ID: 17664076
[TBL] [Abstract][Full Text] [Related]
18. The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice.
Honore P; Donnelly-Roberts D; Namovic M; Zhong C; Wade C; Chandran P; Zhu C; Carroll W; Perez-Medrano A; Iwakura Y; Jarvis MF
Behav Brain Res; 2009 Dec; 204(1):77-81. PubMed ID: 19464323
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of intraplantar Complete Freund's Adjuvant-induced burrowing deficits.
Gould SA; Doods H; Lamla T; Pekcec A
Behav Brain Res; 2016 Mar; 301():142-51. PubMed ID: 26704218
[TBL] [Abstract][Full Text] [Related]
20. Topical anti-inflammatory and analgesic activities of standardized pomegranate rind extract in comparison with its marker compound ellagic acid in vivo.
Mo J; Panichayupakaranant P; Kaewnopparat N; Nitiruangjaras A; Reanmongkol W
J Ethnopharmacol; 2013 Jul; 148(3):901-8. PubMed ID: 23743057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
